Monthly Archives: September 2013

Featured Stories

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Exploding Tanks Kill Jeep Drivers 18 months after Recall

Exploding Gas Tanks Continue to Kill Jeep Drivers 18 months after Recall

Chrysler recalled Jeeps with exploding gas tanks more than 18 months ago, but 1 million+ of these vehicles have not been fixed as the death toll continues to rise.

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Colorado Woman Sues American Medical Systems Over Transvaginal Mesh Injuries

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a Colorado woman allegedly injured by transvaginal mesh products manufactured by American Medical Systems, Inc. The suit was filed on May 21, 2012 in the U.S. District Court for the Northern District of California (Case No. ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

FDA Warns About Increased Death Risk With Tygacil By Pfizer

tygacil_death_risk

Tygacil (tigecycline), an antibacterial manufactured by the drug maker Pfizer, increases the risk of death, whether used for approved uses or for purposes that are off-label, according to a warning just issued by the U.S. food and Drug Administration (FDA). … Continue reading

Posted in Pharmaceuticals |

Medtronic Issued Warning Letter Over Its Diabetes Facility

medtronic_diabetes_FDA_warning

Device maker, Medtronic Inc., was just issued a warning letter from the U.S. Food and Drug Administration (FDA) concerning its Northridge, California diabetes facility. The letter was received on September 19 and discussed procedures involving “corrective and preventative action, complaint … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

Hawaii Liver Failure Cluster may be Tied to Weight Loss/Body Building Supplement

dietary_supplements_liver_failure_

The state of Hawaii is looking into a number of liver failure cases that have occurred in young, healthy adults who all took dietary or nutritional supplements. The state is issuing a public medical alert, according to KHON.com. “A cluster … Continue reading

Posted in Defective Products, DMAA Supplements, Pharmaceuticals |

Sulfonylurea Use Increases Mortality Risk in Type 2 Diabetes Treatment

sulfonylurea_increased_risks

New study results show that first-line therapy with sulfonylureas significantly increases the risk for death in patients with Type 2 diabetes compared to treatment with metformin. The combination of metformin and a sulfonylurea was also associated with a significantly increased … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Cardiac Stent Overuse Tied to Increased Deaths

cardiac_stents_overuse

The issue of cardiac stenting has highlighted potential overuse of the devices that may lead to cardiac complications. Cardiac stenting involves propping open a narrowed coronary artery with a small, metal mesh tube. During emergency surgery, for instance, when a … Continue reading

Posted in Legal News |

Baby Sunscreen Recalled Over Contamination Concerns

baby_sunscreen_recall

W.S. Badger Co. Inc. just issued a recall of all lots of its 4-ounce SPF 30 Baby Sunscreen Lotion and one lot of its 4-ounce SPF 30 Kids Sunscreen Lotion, over concerns the products have been contaminated with microbials, according … Continue reading

Posted in Defective Products, Health Concerns, Product Recalls |

Actos Maker, Takeda, Hid Drug’s Risks from Patients, Doctors

takeda_hid_actos_risks

Another Actos lawsuit alleges that Takeda Pharmaceutical Co., the maker of the Type 2 diabetes drug, put profits before patient safety and “duped” patients. The lawsuit states that Takeda should be held liable in the cancer death of a former … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Study Finds Pradaxa Risky for Patients Implanted with Artificial Heart Valves

Pradaxa has been tied to more serious adverse reactions, according to a new study on Behringer Ingelheim’s blood thinner. The research revealed that when Pradaxa (dabigatran) is taken by patients with mechanical heart valves, there is an increase in risks … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Stryker, Medtronic Lose Preemption Bid in Lawsuit Involving Alleged Off-Label Bone Product Use

stryker_medtronic_court_lose

A preemption bid made by device makers Medtronic and Stryker to dismiss a lawsuit filed over their bone protein products has been rejected. A California state court ruled that federal law does not preempt the case from proceeding, according to … Continue reading

Posted in Defective Medical Devices, Defective Products, Medtronic Infuse |

Heart Medicine Digoxin Leads to Higher Death Rates in Patients

digoxin_higher_death_rates

An article published online recently in the journal Circulation: Cardiovascular Quality and Outcomes found a 72 percent increase in death in heart failure patients treated with Lanoxin (digoxin) compared to those who had never taken the drug. Digoxin is used … Continue reading

Posted in Health Concerns, Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.